Potential health risks of complementary alternative medicines in cancer patients - Wikidata - awgldk - TriplyDB

Potential health risks of complementary alternative medicines in cancer patients

Potential health risks of complementary alternative medicines in cancer patients

http://www.wikidata.org/entity/Q28166863

about

Is there a role for complementary therapy in the management of leukemia?Complementary and alternative medicine: use and disclosure in radiation oncology community practice.Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: A descriptive study How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis.The health benefits of blackcurrants.The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products.Use of herbal medicine during pregnancy among women with access to public healthcare in Nairobi, Kenya: a cross-sectional survey Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.The use of herbal medicines by people with cancer: a cross-sectional survey A pilot study of website information regarding aromatase inhibitors: dietary supplement interactions Cytochrome P450 enzyme mediated herbal drug interactions (Part 2)Dietary calcium supplementation enhances efficacy but also toxicity of EGFR inhibitor therapy for colon cancer.Alternative medicine and doping in sports.An assessment of the impact of herb-drug combinations used by cancer patients.The quantity and quality of complementary and alternative medicine clinical practice guidelines on herbal medicines, acupuncture and spinal manipulation: systematic review and assessment using AGREE II Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors.Breast cancer: patient information needs reflected in English and German web sites.Modeling cancer patient populations in mice: complex genetic and environmental factors Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer.The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy.The effect of Echinacea purpurea on the pharmacokinetics of docetaxel.The use of herbal medicines by people with cancer: a qualitative study.Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia.Potential drug interactions in patients with a history of cancer.Effects of herbal products on the metabolism and transport of anticancer agents.Drug interactions in African herbal remedies.Great expectations: what do patients using complementary and alternative medicine hope for?Drug interactions with phytotherapeutics in oncology.Cancer patients at risk of herb/food supplement-drug interactions: a systematic review.Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis.Assessing health risks of complementary alternative medicines in cancer patients.[Complementary medicine in cancer patients under treatment in Marrakech, Morocco: a prospective study].Use of complementary and alternative medicine by patients with cancer in northern Turkey: analysis of cost and satisfaction.Potential interactions with anticancer agents: a cross-sectional study.Assessment of Drug-Drug Interaction in Ayder Comprehensive Specialized Hospital, Mekelle, Northern Ethiopia: A Retrospective Study.Herbal product use by African American older women.Warfarin and royal jelly interaction.Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014.The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel.Alterations of gefitinib pharmacokinetics by Co-administration of herbal medications in rats.

P2860

Q24642523-97005429-22AB-4D50-B91A-F1B0B7DF5DDD Q30387278-E0764C09-C8FE-4C75-A76D-94359A78722C Q33640541-BA61B1EB-389F-4CCA-9935-BF7C697C7ABE Q34226495-9D95965D-F8AD-48AE-91A6-021E9A5D08BC Q34279376-99C5B18D-D71A-4953-980C-630915636691 Q34432298-7533861C-B3F8-49A1-9246-79C491C52783 Q34502968-5AF4F84D-D249-44ED-80E9-CA7CEF16BB1D Q34722389-331A09B3-FC70-4C15-A9BE-D1CFEC35FDE5 Q34727333-23057492-5A3B-404A-9498-619C4A450B91 Q35565585-46379564-095C-4E88-909E-6304F16A42BD Q35729029-439CEBE7-33A2-4872-BE8A-385104FBBE22 Q35911660-7C7A0252-AB76-4FAA-9B77-BA62CE03B630 Q36147651-9F6D0A8A-D0B9-4B96-9A22-CBC6D3621FE5 Q36166875-A4576B50-C38B-47E2-8D4C-814CECFFAF07 Q36177578-22348FAF-160E-42F4-813F-0F6142857756 Q36337973-ABEEFFC7-5B9D-44AE-8E7F-C809BDFDF4E4 Q36696079-05D5F0E2-E0E8-48F3-83B5-11F7B56B73A0 Q36838654-33A10F21-1921-4B3F-A559-19252091A1A7 Q37064936-FF9C702D-20DA-4025-8647-493C1D731C68 Q37159550-589ACCA6-D684-4481-BB7C-F03D1C4588C8 Q37161914-17DA2170-6F88-47F3-AF19-527CB297E4FB Q37201027-B83DDF32-14B2-41EF-89F8-5F6CD7D5843D Q37577950-6A3876A0-337A-459A-BA7C-DC7692D8D6D0 Q37719619-393F2D55-E7C5-45AB-A646-78EEAD50C58D Q37779320-54A4CA61-EE27-40C0-87C7-D3F8F7D14FCC Q37901060-500A082E-8E82-4933-B955-BCA62828AE9A Q37902208-E75EEC3C-DAAE-473B-B5E0-11435BA80A2C Q38175476-DA63BCBE-1D7E-4F99-88BE-4949563F3A6B Q38243383-C552568C-E89E-4652-A09F-B1E79A036DDE Q38585273-B86C7AD5-2BB3-49B5-B6E1-93D631C32B3A Q43236989-8588347F-C7C2-4500-9CBF-1A5B61C94415 Q44047975-62079119-8990-4E34-AE0F-2E105B6E7070 Q44452616-C97F3E05-E60F-4B60-B5DC-4568974AF59F Q46224729-8AD39F9D-E90A-4B39-953B-136F7D79156F Q46314496-BE4058FA-A740-42B2-8A8B-0A3BEBCCD3D0 Q46681126-879FAB09-24F5-431C-B9F7-2F1D64591C61 Q46689844-5A83224B-E544-4C5E-8D24-2780E556ECE1 Q47358362-98EB1201-5171-4762-AF8B-C28574E7BF9B Q47928719-2892DDD8-A096-47F1-AC9A-57D2B79CE549 Q50041679-0DB6B11E-4F5F-458D-B590-FA1454AE9E21

P2860

Potential health risks of complementary alternative medicines in cancer patients

http://www.wikidata.org/entity/Q28166863

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Potential health risks of complementary alternative medicines in cancer patients

@ast

Potential health risks of complementary alternative medicines in cancer patients

@en

Potential health risks of complementary alternative medicines in cancer patients

@nl

type

label

Potential health risks of complementary alternative medicines in cancer patients

@ast

Potential health risks of complementary alternative medicines in cancer patients

@en

Potential health risks of complementary alternative medicines in cancer patients

@nl

prefLabel

Potential health risks of complementary alternative medicines in cancer patients

@ast

Potential health risks of complementary alternative medicines in cancer patients

@en

Potential health risks of complementary alternative medicines in cancer patients

@nl

P1433

Q28166863-B845066C-1CAE-4DEE-8030-CFA8A0F68A77

P1476

Q28166863-B92B4BDB-E368-408E-944D-7BF56A8B8D49

P2093

Q28166863-68F3A452-3D56-44EA-A2B0-90695AAB71C9

Q28166863-A83BBE65-7F69-493E-A8F0-379EFF271D5D

Q28166863-BDB67115-F271-4F6C-B832-AEC299941825

Q28166863-C49A07FF-2CEB-4A21-B74A-7E424F74FE3D

Q28166863-DC7A42C7-69AE-4620-8792-21F413D0169C

P2860

Q28166863-029A8D27-9FB2-4169-B4AB-22C115EDDD39

Q28166863-04E6AF83-67FA-44B6-A69E-46F16116D064

Q28166863-05E3FC24-9C3E-4A49-AAB8-FCAAA1C4A38C

Q28166863-0735CBDF-785F-497C-8B41-DEAB716A825C

Q28166863-0A195FAF-2AF4-4BCF-B24D-A73025FB9276

Q28166863-0EBB14B7-F629-42BE-875E-5565D24307C3

Q28166863-142CCAF2-EAAA-4ACB-B6C2-20625502BE90

Q28166863-18A84C4C-7CC1-4369-8B8E-DD970503CA46

Q28166863-206B46CA-6DFD-418B-BE85-2EBFDFCDF839

Q28166863-21DB1B92-44B3-48F0-A55B-FD4F32C0EC7A

P2888

Q28166863-48BAA6A8-A316-426A-A9AA-924C474AAA7D

P304

Q28166863-AEEA74C7-772F-449B-840D-D07A26CC023D

P31

Q28166863-3CCB3E4E-6C2A-4056-BCF5-2A41B995B5C7

P3181

Q28166863-6781CE3A-02B9-470A-8946-CA0722B808F3

P356

Q28166863-FED1C746-4F56-4D12-ACA0-1E5A4B5496FB

P407

Q28166863-941F22E2-84D9-4665-9C6E-9C4CC4D8A278

P433

Q28166863-8C71898F-B96B-4056-9EC3-02B44B26CA3F

P478

Q28166863-5FF9B8E1-B2DC-4351-86A9-11BC885FCEED

P50

Q28166863-81799C30-83F0-480B-A913-1B444F515DAE

P577

Q28166863-B8E52AAA-D355-4C91-BACB-4C301BBD91F7

P5875

Q28166863-A3BD264E-9AB3-49EB-B9BD-504B7A09FC7F

P6179

Q28166863-C8811173-C726-4CDA-9DA9-F8E9FB8B03FD

P698

Q28166863-1C554E7D-09FA-4144-869F-5B5F206590CF

P932

Q28166863-2428983B-6B92-4650-AE76-422D0216AFCC

P3181

P356

P1433

British Journal of Cancer

P1476

Potential health risks of complementary alternative medicines in cancer patients

@en

P2093

C Seydel

http://www.w3.org/2001/XMLSchema#string

D Fannon

http://www.w3.org/2001/XMLSchema#string

J Earl

http://www.w3.org/2001/XMLSchema#string

O Horn

http://www.w3.org/2001/XMLSchema#string

P Crichton

http://www.w3.org/2001/XMLSchema#string

P2860

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology

Hazard assessment of germanium supplements

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

Interactions between herbal medicines and prescribed drugs: a systematic review.

How useful are unconventional cancer treatments?

Herb-drug interactions.

Unsafe and potentially safe herbal therapies.

The vitamin A spectrum: from deficiency to toxicity.

Potential interactions between alternative therapies and warfarin.

P2888

P304

408-413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2748033

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.BJC.6601560

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8910209

http://www.w3.org/2001/XMLSchema#string

P6179

1002935887

http://www.w3.org/2001/XMLSchema#string

P698

14735185

http://www.w3.org/2001/XMLSchema#string

P932

2410154

http://www.w3.org/2001/XMLSchema#string